COVID-19-Induced New-Onset Diabetes: Trends and Technologies

Area of Science:

• Endocrinology
• Infectious Diseases
• Public Health

Background:

• The COVID-19 pandemic has impacted global health, with significant morbidity and mortality.
• Pre-existing diabetes is a risk factor for severe COVID-19 outcomes.
• Emerging evidence suggests a link between COVID-19 infection and new-onset diabetes or worsening of existing diabetes.

Purpose of the Study:

• To review the current understanding of the epidemiology and mechanisms underlying the bidirectional relationship between COVID-19 and diabetes.
• To identify challenges in studying COVID-19-induced diabetes and propose solutions.
• To highlight the role of emerging technologies in diabetes research.

Main Methods:

• Literature review of epidemiological data and mechanistic studies.
• Analysis of challenges in clinical research and patient monitoring.
• Exploration of advancements in wearable technology and microsampling for diabetes management.

Main Results:

• COVID-19 may increase the risk of hyperglycemia and diabetes complications in both diabetic and non-diabetic individuals.
• The exact type of diabetes induced by COVID-19 (Type 1, Type 2, or atypical) remains unclear.
• The long-term risk of new-onset diabetes and complications in COVID-19 survivors requires further investigation.

Conclusions:

• A complex bidirectional relationship exists between COVID-19 and diabetes, necessitating further research.
• Overcoming research challenges requires innovative approaches and technological integration.
• Wearable technologies and microsampling offer promising avenues for studying and managing diabetes in the context of COVID-19.